News and Events

Massachusetts General Hospital reports on news from the Neurology Service on clinical trials, progress in neuroscience research, and recognition for clinical excellence.


Currently Browsing:2016

  • Blood Tests for Brain Cancer

    Monday, October 17, 2016  Mass General

    A Massachusetts General Hospital Neurosurgeon Works to Develop the First Blood-Based Test for Patients with Brain Tumors.

  • Once again, named among America's best hospitals

    Tuesday, August 02, 2016  Mass General

    Massachusetts General Hospital is once again named among the top hospitals in America by U.S. News & World Report and is the only hospital to be highly rated across all 16 specialties.

  • Mass General receives awards for exceptional stroke care

    Sunday, July 10, 2016  Mass General

    Massachusetts General Hospital has received two awards from the Paul Coverdell National Acute Stroke Program at the Massachusetts Department of Public Health.

  • Care team honored at fourth annual Stroke Breakfast Gala

    Friday, June 10, 2016  Mass General

    About 7:15 AM on Jan. 7, now 54-year-old Jang-Ho Cha, MD, PhD, translational medicine head for Neuroscience at Novartis, was going through his morning routine. Cha walked downstairs in his Boston home, made a pot of coffee, took a shower and put his contact lenses in. It was when he began brushing his teeth that he noticed something was wrong.

  • Seized: Inside the Mystery of Epilepsy

    Monday, May 23, 2016  Research

    Moving documentary on Epilepsy, featuring Mass General Epilepsy expert, Dr. Andrew Cole, Division Chief, Clinical Neurophysiology.

  • NeuroBlast Spring 2016

    Monday, May 16, 2016  Mass General

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, psychiatry, and neuroscience from Massachusetts General Hospital.

  • A Patient's Astonishing Recovery from Brain Trauma Provides Hope for New Treatments

    Friday, May 13, 2016  Clinical

    Dylan’s recovery has provided Dr. Edlow and his laboratory important information about the timeline used for prognosis in the case of traumatic brain injuries. The information has encouraged clinicians not to limit care too quickly, and has provided a measure of hope for families.

  • Focus on Functional Neurological Disorders

    Tuesday, January 19, 2016  Research

    “Many patients come in worried that they will not be heard. At our clinic, they learn that FND is a real neuropsychiatric condition, and if they meet the criteria, we provide a clear diagnosis,” says Dr. Perez

  • PET Theories: New Imaging Tools Offer Better Diagnosis, Treatment of Neurodegeneration

    Tuesday, January 19, 2016  Research

    “Making the correct molecular diagnosis is a critical step if we are to find medicines that work in people,” says Gomperts.

  • Innovations in Spinal Cord Tumor Surgery

    Tuesday, January 19, 2016  Research

    “Spinal cord monitoring requires a careful interplay between the surgeon, anesthesia, and the monitoring team. We’re really privileged to have such a dedicated group of individuals who have been with us quite a long time doing this work. It’s the teamwork that has allowed us to capitalize [on the new innovations],” Borges says.

  • Molecular Approach to Brain Tumors Improves Treatment

    Tuesday, January 19, 2016  Research

    “As we look to treat patients in the future, there is an emerging imperative to arrive at an integrated diagnosis,” says Cahill, one that encompasses both histological and molecular data.

  • NeuroBlast e-Newsletter January 2016

    Tuesday, January 19, 2016  Research

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.

Currently Browsing:2015

  • Steve Gleason Act scores victory for ALS patients on Capitol Hill

    Wednesday, July 22, 2015  Mass General

    The bill, which now needs only Obama's signature to become a law, will make critical technology available to patients with ALS and other neurological disorders through Medicare and Medicaid. That includes innovative speech-generating devices like the one Gleason uses to type words through eye movements.

  • #1 in the Nation

    Tuesday, July 21, 2015  Mass General

    U.S. News & World Report has named Massachusetts General Hospital the #1 hospital in the nation based on our quality of care, patient safety and reputation in 16 clinical specialties.

  • New Clinical Pilot Studies Will Use Biomarkers to Speed Therapy Development

    Monday, July 13, 2015  Research

    The ALS Association and the ALS Finding a Cure Foundation are pleased to announce $3 million in funding for two new Phase II clinical studies through the ALS Accelerated Therapeutics (ALS ACT) initiative.

  • Robert G. Miller awarded $1.5 million grant to help fund Neuraltus' Phase 2 clinical study

    Monday, July 13, 2015  Research

    The Phase 2 study is intended to help confirm the potential clinical benefits seen in the previous study of NP001, the results from which were published in the April 2015 issue of Neurology: Neuroimmunology & Neuroinflammation, an official journal of the American Academy of Neurology.

  • NeuroBlast e-Newsletter July 2015

    Thursday, July 09, 2015  Research

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.

  • Testifying in support of TeleStroke

    Friday, June 05, 2015  Mass General

    As the momentum of TeleStroke grows, MGH doctors are supporting ways to expand this treatment to more patients - including testifying before the U.S. Senate in support of the Furthering Access to Stroke Telemedicine (FAST) Act.

  • Circadian Dysfunction in Parkinson's Disease

    Monday, June 01, 2015  Mass General

    New research from Massachusetts General Hospital investigates the role of circadian rhythm dysfunction in the pathophysiology of Parkinson’s disease.

  • MGH ALS Symposium Video

    Tuesday, May 12, 2015  Research

    Hear from the MGH Neurology Department researchers and clinic staff dedicated to finding treatments and cures for ALS.

  • Endovascular Clot Retrieval Therapy: Implications for the Organization of Stroke Systems of Care

    Monday, May 11, 2015  Research

    Endovascular acute ischemic stroke therapy is now proven by randomized controlled trials to produce large, clinically meaningful benefits. In response, stroke systems of care must change to increase timely and equitable access to this therapy. In this review, we provide a North American perspective on implications for stroke systems, focusing on the United States and Canada, accompanied by initial recommendations for changes.

  • Supporting Stroke Services

    Friday, May 01, 2015  Mass General

    Lee H. Schwamm, MD, executive vice chairman of Neurology and director of the Mass General Stroke Service, shares information about strokes, warning signs and advances in stroke care.

  • Neurology residents practice what they preach

    Friday, March 06, 2015  Mass General

    Several MGH and MassGeneral Hospital for Children (MGHfC) neurologists are saying goodbye to carbohydrates and sweets for the month. In order to support their patients, spread awareness about the effectiveness of dietary therapy and raise funds for the department, six neurologists – both pediatric and adult – are participating in a Low Glycemic Index Therapy (LGIT) diet, which often is used in the treatment of pediatric epilepsy patients.

  • The Division of Sleep Medicine Receives Program Accreditation

    Friday, February 27, 2015  Mass General

    The Division of Sleep Medicine at Massachusetts General Hospital in Boston recently received program accreditation from the American Academy of Sleep Medicine (AASM).

  • New year, better sleep

    Friday, January 16, 2015  Mass General

    Better sleep is a resolution that should be on everyone’s list, according to Josna Adusumilli, MD, an MGH neurologist and sleep specialist. But when it comes to sleep, how much is enough and what is the best way to get restful sleep? Adusumilli explains.

  • Increasing Surgical Options for Epilepsy Patients

    Thursday, January 01, 2015  Clinical

    Advances in pre-surgical evaluation methods have made it possible to more accurately identify the epileptogenic region and minimize risk of injury to the functional cortex, enabling more epilepsy patients to receive surgical treatment.

Currently Browsing:2014

  • Earlier tPA Treatment for Ischemic Stroke

    Monday, December 01, 2014  Mass General

    Massachusetts General Hospital researchers joined hospitals from around the country to demonstrate the effectiveness of a treatment for ischemic stroke and create a set of standards to expedite treatment delivery.

  • Mass General Neuroendovascular Care: New Technologies Help to Save Lives

    Wednesday, November 19, 2014  Mass General

    “Every patient's problems, risk factors and social situations are so individual. Treatment should be individually tailored to best meet their needs and expectations” says Dr. Leslie-Mazwi.

  • Sleep Research: Do Try This At Home

    Tuesday, November 18, 2014  Clinical

    About 10 percent of Americans suffer from sleep apnea, a disorder of nighttime breathing that disrupts sleep but often goes undiagnosed. Apnea can lead to daytime drowsiness, which puts people at risk of accidents and injuries. Poor sleep due to apnea or other causes also raises the chances of developing high blood pressure, diabetes, depression, heart disease and stroke.

  • NeuroBlast e-Newsletter June 2014

    Saturday, November 01, 2014  Mass General

    This issue examines the latest trends in Epilepsy research, clinical care and neurosurgery.

  • Russell Museum Fall Lecture Series

    Thursday, September 11, 2014  Mass General

    All MGH Russell Museum lectures are open to the public. To register, please email

  • Arteriovenous malformation triggers a patient's near-fatal hemorrhage

    Monday, September 08, 2014  Mass General

    Software engineer Lori Corbani was never sick. Yet one day, she was rushed to Massachusetts General Hospital after suffering a near-fatal brain hemorrhage triggered by a congenital condition.

  • Decompressing After School: Students with an Autism Spectrum Disorder

    Monday, September 08, 2014  Mass General

    Many children and teens on the autism spectrum expend a lot of energy to “hold it together” just to make it through the school day. When they get home from school they could benefit from a little time to decompress. Here are strategies parents can use to help facilitate this process.

  • Slaugenhaupt named scientific director of MGH Research Institute

    Friday, August 22, 2014  Mass General

    Susan Slaugenhaupt, PhD, of the MGH Center for Human Genetic Research and professor in the Department of Neurology, has been named the first scientific director of the MGH Research Institute.

  • Albers honored with Wilkens endowed chair

    Friday, August 22, 2014  Mass General

    Mark Albers, MD, PhD, of the Department of Neurology, was named the first incumbent of the Frank Wilkens, Jr. and Family Endowed Chair in Alzheimer’s Disease Research.

  • Fundraising and fighting for a cure

    Friday, August 15, 2014  Mass General

    In 2012, when 30-year-old Quincy resident Alex Cellucci was nine months pregnant, she was diagnosed with neurofibromatosis, a genetic disorder that disturbs cell growth in the nervous system, enabling tumors to grow on any nerve in the body.

  • #1 in New England, #2 in the nation

    Tuesday, July 15, 2014  Mass General

    U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.

  • NeuroBlast e-Newsletter

    Tuesday, June 24, 2014  Clinical

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.

  • New device brings hope to epilepsy patients

    Thursday, June 19, 2014  Mass General

    After years of seizures, a new device gives one Mass General epilepsy patient a new lease on life.

  • Every second counts

    Friday, June 13, 2014  Mass General

    When it comes to treating stroke patients, every second counts.

  • The MGH Epilepsy Service – Where Complexity Meets Innovation

    Wednesday, June 04, 2014  Mass General

    A young Albanian architect found help for his seizure disorders thanks to a unique team of specialists from the Department of Neurology at Massachusetts General Hospital.

  • Will New Research Redefine Epilepsy?

    Wednesday, May 28, 2014  Mass General

    Recent research is challenging the traditional definition of epilepsy as an expression of increased excitability and firing of a group of neurons. This has major implications for clinical treatment.

  • The MGH Epilepsy Service – Where Complexity Meets Innovation

    Tuesday, May 27, 2014  Mass General

    When Elton, a young Albanian architect, couldn’t find treatment for his disabling seizures in Albania, he traveled 500 miles to Austria to meet with Massachusetts General Hospital (MGH) Epilepsy Service Director Andrew J. Cole, MD. Dr. Cole, in Austria on a business trip, felt Elton was a good candidate for surgery and brought his case back to his colleagues in Boston.

  • Mass General recognized for stroke care

    Wednesday, May 14, 2014  Mass General

    Massachusetts General Hospital is the recipient of the 2014 Get With The Guidelines-Stroke Gold-Plus Quality Achievement Award and the Target: Stroke Honor Roll. These awards, sponsored by the American Stroke Association and the American Heart Association, recognize hospitals that provide the highest quality stroke care.

  • Northeast ALS Consortium (NEALS) Website Offers Resources for Patients and Researchers

    Friday, January 31, 2014  Research

    The Northeast ALS Consortium (NEALS) website is devoted to supporting clinical research of Amyotrophic Lateral Sclerosis (ALS) and other motor neuron disease (MND).

  • ALS Clinical Trials Liaison Available to Help Connect PALS With Clinical Research Information

    Thursday, January 30, 2014  Research

    NEALS and ALSA partner to offer clinical trial liaison service to help people with ALS navigate the world of clinical research.

Currently Browsing:2013

  • Alzheimer’s Disease Gene Discovery & Drug Discovery

    Wednesday, December 11, 2013  Research

    “This is the largest collection of familial Alzheimer’s whole-genome sequences in the world,” Dr. Tanzi says, comprising half a petabyte of data, equivalent to the entire contents of the Library of Congress. “This is as big as big data gets.” 

  • Spinal Metastases & Stereotactic Radiosurgery

    Tuesday, December 10, 2013  Clinical

    Radiosurgery has shifted the paradigm of treating patients by minimizing the morbidity of conventional surgery and, focusing on tumor control.

  • Dietary Therapy for Pediatric Epilepsy

    Tuesday, December 10, 2013  Mass General

    Dietary therapy is prescribed most often for patients with refractory epilepsy, whose seizures have not been controlled despite trying multiple antiepileptic drugs.

  • Tau Pathology Spreading out from the Entorhinal Cortex Can be Reversed

    Tuesday, December 10, 2013  Research

    Neurofibrillary tangles - largely composed of tau protein- are one of the two pathological hallmarks of Alzheimer’s disease.

  • Alzheimer's Early Treatment

    Tuesday, December 10, 2013  Research

    Can anti-amyloid antibody treatment reverse Alzheimer’s disease pathology before memory loss sets in?

  • Alzheimer’s Preclinical Disease Biomarker

    Tuesday, December 10, 2013  Research

    Mark Albers, MD, PhD, is developing a set of simple but powerful tools to screen for the very earliest stages of preclinical Alzheimer’s Disease.

  • NeuroBlast e-Newsletter December 2013

    Tuesday, December 10, 2013  Mass General

    In this issue: spinal metastases & stereotactic radiosurgery; skull base tumors & endoscopic surgery; pediatric epilepsy dietary therapy; Alzheimer Disease: tau pathology; drug & gene discovery; early treatment; preclinical diagnostic tools.

  • Strides in Understanding and Treating ALS

    Sunday, December 01, 2013  Mass General

    The Northeast ALS Consortium, co-founded by Massachusetts General Hospital researcher Merit Cudkowicz, MD, has spurred basic and translational research that has led to investigational therapies and improved patient outcomes.

  • "The Art of Illness"

    Friday, November 01, 2013  Mass General

    Paul S. Russell, MD Museum of Medical History and Innovation invites you to attend its latest lecture in its evening series

  • Ihn Sik Seong: The Long Search for the Full Story of Huntington’s Disease

    Tuesday, September 10, 2013  Research

    Understanding the molecular pathogenesis of Huntington’s disease.

  • Use of clot-dissolving drug for ischemic stroke nearly doubled from 2003 to 2011.

    Friday, August 30, 2013  Mass General

    A team of researchers reports both an overall increase in the use of tPA to dissolve clots blocking arteries supplying the brain and administration of the potentially life-saving drug to a more diverse group of patients.

  • Anne B. Young, MD, PhD, Fellowship in Therapeutic Development 2014

    Wednesday, August 28, 2013  Research

    Applications are being sought for a joint MGH/Biogen Idec two-year training program in translational neuroscience.

  • Neurology Infusion Center: A feeling of family

    Friday, August 16, 2013  Mass General

    The MGH Neurology Infusion Center is an ambulatory outpatient unit that delivers infusion and intravenous (IV) services to patients, ages 18 and older, who have a variety of neurological disorders. On average, the unit sees 12 to 14 patients per day but more referrals from MGH clinicians for ambulatory patients are welcome.

  • A brain cancer "warrior" takes the trip of a lifetime

    Wednesday, July 31, 2013  Mass General

    Mass General patient Michelle Beale's journey started with debilitating headaches. Now she's traveling around the world.

  • Concussion

    Monday, July 22, 2013  Clinical

    When neurosurgeon Tina Duhaime, MD, of the MGH Youth Sports Concussion Clinic, talks with families about concussion, she takes time to explain what is known, and just as importantly, what isn’t known, about this common injury.

  • TeleStroke: Real-time Resources for Better Patient Care

    Monday, July 22, 2013  Clinical

    Through the TeleStroke network, 30 emergency departments across the northeast have real-time access to stroke experts 24 hours a day, seven days a week.

  • E Pluribus Unum for Parkinson Disease - Researchers Draw on Sources to Improve Treatment of PD

    Monday, July 22, 2013  Clinical

    What do Gaucher’s disease, gout, and amyloid plaques have in common? For researchers at the MGH, each of them may shed light on the causes and treatment of Parkinson’s disease.

  • NeuroBlast e-Newsletter

    Monday, July 22, 2013  Clinical

    NeuroBlast: the newsletter of translational neuroscience and clinical care advances in neurology, neurosurgery, and neuroscience from Massachusetts General Hospital.

  • #1 in New England, #2 in the nation

    Tuesday, July 16, 2013  Mass General

    U.S. News & World Report ranks Massachusetts General Hospital among the top hospitals in America based on our quality of care, patient safety and reputation in 16 specialties.

  • It takes a team

    Friday, June 28, 2013  Mass General

    The MGH Acute Stroke Care Team was honored with the 2012 Acute Stroke Champion Award at the MGH Acute Stroke Gala Breakfast.

  • Informatics Core at MIND: Building Tools, Creating Connections

    Thursday, March 14, 2013  Research

    The Informatics Core at MIND offers state-of-the-art bioinformatics services, connecting researchers with tools, each other, and expertise to manage their clinical and research databases.

  • Lessons learned through pages turned

    Friday, January 25, 2013  Mass General

    When it came time for Bryn Seltzer, 13, of Needham, to choose her bat mitzvah project, she knew she wanted to give back to the Pediatric Epilepsy Program at MassGeneral Hospital for Children (MGHfC), which had cared for her since she was 6 years old.

Currently Browsing:2012

  • Cure Alzheimer’s Fund donates $5.4 million

    Friday, October 26, 2012  Mass General

    On Oct. 18, at a press conference in Cambridge, the Cure Alzheimer’s Fund announced a fitting $5.4 million contribution to the MGH to fund state-of-the-art whole genome DNA sequencing that aims to enhance understanding of the genetic roots of Alzheimer’s.

  • New neurology chief shares lessons

    Friday, October 05, 2012  Mass General

    The 15th Annual Women in Medicine Month Celebration on Sept. 20 featured a keynote lecture by Merit Cudkowicz, MD, chief of Neurology.

  • New Mass General Center to Help Speed Development of Neurological Treatments

    Friday, September 14, 2012  Mass General

    Mass General received a $20 million grant to establish a nationwide clinical coordinating center for testing drugs that can help people with diseases of the brain such as Alzheimer’s disease.

  • Boosting metabolism at work

    Friday, August 10, 2012  Mass General

    Research has shown that sitting for extended periods may not only negatively affect health but also may prematurely shorten lifespan. Marie Pasinski, MD, offers five ways to incorporate more activity into the workday.

  • All’s Quiet on the Lunder Floors

    Monday, July 16, 2012  Mass General

    The Lunder Building is leading a noise-reduction revolution. Thanks to careful planning and innovative thinking, patients rest and receive treatment in a quiet healing environment.

  • Not Your Typical Rash: Why Shingles Can't Be Taken Lightly

    Thursday, May 31, 2012  Mass General

    Anne Louise Oaklander, MD, PhD, associate professor of Neurology, says shingles and post-herpetic neuralgia (PHN), a serious neurological complication in which pain lingers in an area of previous shingles long after the rash heals, cannot be taken lightly. PHN can last for months or years and is a source of severe and disabling pain, particularly for older patients.

  • Mind over matter

    Friday, May 25, 2012  Mass General

    Nearly 15 years after a stroke left her paralyzed and unable to speak, 59-year-old Cathy Hutchinson controlled a robotic arm to lift coffee to her mouth and take a drink by thinking about moving her own arm.

  • 2012 Research Scholars announced

    Friday, May 25, 2012  Mass General

    The second group of MGH Research Scholars – recipients of unrestricted five-year grants to support innovative investigations – was announced at the hospital’s Research Advisory Council (RAC) annual meeting on May 11.

  • Responsibility with a smile

    Friday, May 04, 2012  Mass General

    In her 30 years as a member of the Child Neurology Department, Ginny Tosney-Trask has “become legendary for her humanity, warmth and generosity.”

  • In Memoriam: C. Miller Fisher, MD

    Friday, April 20, 2012  Mass General

    C. Miller Fisher, MD, founder of the MGH Stroke Service and widely regarded as the father of stroke neurology, died April 14 at the age of 98.

  • Appointments announced

    Friday, March 23, 2012  Mass General

    THE MGH WILL WELCOME new chiefs for the Department of Neurology and the Department of Urology later this spring.

Currently Browsing:2011

  • MGH ranks #2 in nation

    Tuesday, July 19, 2011  Mass General

    MGH ranks #2 in 2011-2012 U.S. News & World Report "Best Hospitals" rankings

  • Care redesign teams move forward with recommendations

    Friday, July 01, 2011  Mass General

    The Partners Strategic Initiative is an ongoing effort to improve care and increase efficiency across all Partners institutions, including the MGH.

  • Third Annual Tarbell Lecture features Anne B. Young, MD, PhD

    Friday, June 10, 2011  Mass General

    MGH Hotline 6.10.11 A world-renowned neurological researcher and clinician who has helped break down barriers for women in her field, Anne B. Young, MD, PhD, chief of the Department of Neurology, has a great deal of wisdom and insight to offer to colleagues.

  • Anne Young, MD, PhD, donates $1M to Department of Neurology

    Friday, April 08, 2011  Mass General

    ANNE YOUNG, MD, PHD, chief of Neurology, made history for women in academic medicine by making a $1 million gift to the Department of Neurology through a deferred charitable gift annuity.

  • Lunder Building patient floors enhance patient- and family-oriented care

    Friday, March 11, 2011  Mass General

    The top five floors of the Lunder Building are dedicated adult inpatient units for neuroscience and cancer patients. While the patient floors follow a standard design, each has highlights specific to a particular patient population. This week, MGH Hotline will highlight unique features of Floors 6 through 8, which are devoted to neuroscience patients, and provide a general description of a Lunder Building inpatient room. A subsequent issue will focus on Floors 9 and 10, which are dedicated to cancer patients, and will highlight the Lunder Building’s nursing, support services and common areas.

  • Lunder Building to “Go Live” this summer

    Friday, February 18, 2011  Mass General

    MGH Hotline 2.18.11 In preparation for the summertime transition of several hospital programs and services to the Lunder Building, the MGH Go Live Group for the new facility was established under the auspices of Jean Elrick, MD, senior vice president for Administration.

  • Acute Stroke Quality Task Force recognizes fastest treatment time

    Friday, February 04, 2011  Mass General

    MGH Hotline 02.04.11 TIME IS BRAIN when it comes to treating stroke.

Currently Browsing:2010

  • MGH ranks among top

    Friday, July 16, 2010  Mass General

    The MGH ranked third among the country's top hospitals on the annual list of "America's Best Hospitals" issue of U.S. News & World Report.

  • MGH residents and fellows make great save during soccer game

    Friday, July 16, 2010  Mass General

    SPAIN MAY HAVE WON the World Cup, but a team of MGH medical residents and fellows had a victory of their own on the soccer field this summer when they helped save the life of another player.

  • Overcoming the odds

    Friday, May 28, 2010  Mass General

    MGH Hotline 5.28.10

  • Surviving a brain stem stroke

    Wednesday, March 10, 2010  Mass General

    Stroke is one of the leading causes of serious, long-term disability in the United States. The Stroke Service at the Massachusetts General Hospital Vascular Center successfully treat one of emergency medicine’s toughest stroke cases.

  • Cutting-edge research, industry-changing model of care improves the lives of patients

    Thursday, January 07, 2010  Clinical

    Duchenne muscular dystrophy (DMD) is the most prevalent and aggressive type of muscular dystrophy, affecting one in every 3,500 live male births in the world. It is also one of the most common lethal genetic diseases of children worldwide.

Currently Browsing:2009

  • In Memoriam: Lisa Krivickas, MD

    Friday, October 02, 2009  Mass General

    MGH Hotline 10.02.09 Lisa Krivickas, MD, associate chief of the MGH Department of Physical Medicine and Rehabilitation and a physician in the Department of Neurology, died of amyotrophic lateral sclerosis (ALS), or Lou Gehrig's disease, Sept. 22 at the age of 45.

  • Tuberous Sclerosis Complex

    Tuesday, July 21, 2009  Mass General

    The Carol and James Herscot Center for Tuberous Sclerosis Complex (TSC) at Massachusetts General Hospital and MassGeneral Hospital for Children is using genetic research to better understand TSC and other diseases like cancer, autism and obesity.

  • Turning thoughts into action

    Monday, June 15, 2009  Mass General

    Dr. Leigh Hochberg from the Department of Neurology at Massachusetts General Hospital is using neurotechnology to harness brain signals that accompany movement. The ultimate goal of the work is to "turn thought into action," with the hope of one day assisting people with ALS, spinal cord injury and stroke to regain control over their environment.

  • Videoconferencing can increase patient access to stroke specialists

    Monday, May 18, 2009  Mass General

    Massachusetts General Hospital neurologist Dr. Lee Schwamm leads a national policy endorsing telestroke as an effective means of stroke evaluation.

Currently Browsing:2008

  • Home for Christmas

    Friday, December 19, 2008  Clinical

    One year ago, a team of intensive care experts at Massachusetts General Hospital collaborated to save Karla Leavenworth's life.

  • New screening tool for identifying major depression in patients with epilepsy

    Monday, September 15, 2008  Mass General

    Commentary on NDDI-E screening tool for detecting symptoms of major depression, while excluding adverse effects of antiepileptic drugs or temporal lobe epilepsy memory problems

Press Releases

  • Human amyloid-beta acts as natural antibiotic in the brains of animal models - 5/25/2016, Research

    A new study from Massachusetts General Hospital investigators provides additional evidence that amyloid-beta protein – which is deposited in the form of beta-amyloid plaques in the brains of patients with Alzheimer’s disease – is a normal part of the innate immune system, the body’s first-line defense against infection.

  • Novel compound has promise for treatment of Huntington's disease - 7/14/2016, Research

    A major, multi-institutional study based at Massachusetts General Hospital has identified a promising treatment strategy for Huntington’s disease (HD). The novel compound identified by the research team appears to protect against neurodegeneration in cellular and animal models of HD by two separate mechanisms.

  • Lower weight in late life may increase risk of Alzheimer's Disease - 8/2/2016, Research

    Researchers at Massachusetts General Hospital and Brigham and Women’s Hospital have found an association between lower weight and more extensive deposits of the Alzheimer’s-associated protein beta-amyloid in the brains of cognitively normal older individuals.

  • Study reveals mechanism behind most common form of inherited Alzheimer’s disease - 3/4/2015, Research

    A study from MGH and BWH researchers reveals for the first time exactly how mutations associated with the most common form of inherited Alzheimer’s disease produce the disorder’s devastating effects. The paper provides an possible explanation for the failure of drugs designed to block presenilin activity.

  • Mood, Anxiety Disorders Common in Tourette Patients - 3/9/2015, Research

    A new study of Tourette syndrome (TS) led by researchers from the University of California at San Francisco and MGH has found that nearly 86 percent of patients who seek treatment for TS will be diagnosed with a second psychiatric disorder during their lifetimes, and that nearly 58 percent will receive two or more such diagnoses.

  • 'Alzheimer's protein' plays role in maintaining eye health and muscle strength - 6/9/2015, Research

    Amyloid precursor protein (APP), a key protein implicated in the development Alzheimer's disease, may play an important role in eye and muscle health. In a new report, scientists have discovered that when proteins that bind to the APP, called FE65 and FE65L1, are deleted, they cause cataracts and muscle weakness in mice.

  • Study reveals effects of chemoradiation in brains of glioblastoma patients - 8/17/2015, Research

    A study from MGH Cancer Center researchers – the first to examine the effects of combined radiation and chemotherapy on the healthy brain tissue of glioblastoma patients – reveals not only specific structural changes within patients’ brains but also that the effect of cancer therapy on the normal brain appears to be progressive and continues even after radiation therapy has ceased.

  • Study finds how Alzheimer's-associated protein tangles spread through the brain - 10/26/2015, Research

    MGH investigators have discovered a mechanism behind the spread of neurofibrillary tangles – one of the two hallmarks of Alzheimer’s disease – through the brains of affected individuals. The research team found how an extremely version of the tau protein is able to spread from one neuron to another in the brains of Alzheimer’s patients.

  • High-calorie feeding may slow progression of ALS - 2/27/2014, Research

    Increasing the number of calories consumed by patients with amyotrophic lateral sclerosis (ALS) may be a relatively simple way of extending their survival. A phase 2 clinical trial led by Massachusetts General Hospital physicians found that ALS patients receiving a high-calorie, high-carbohydrate tube-feeding formula lived longer with fewer adverse events than participants who received a standard formula designed maintain their weight.

  • In recognizing speech sounds, the brain does not work the way a computer does - 4/30/2014, Research

    How does the brain decide whether something is correct? When it comes to the processing of spoken language, the theory has been that the brain applies a set of rules to determine which combinations of sounds are permissible. Now the work of MGH investigators suggests that the brain decides based on the words that are already known.

  • Novel culture system replicates course of Alzheimer’s disease, confirms amyloid hypothesis - 10/12/2014, Research

    An innovative laboratory culture system has succeeded, for the first time, in reproducing the full course of events underlying the development of Alzheimer’s disease. Using the system they developed, MGH investigators provide the first clear evidence supporting the hypothesis that deposition of beta-amyloid plaques in the brain is the first step in a cascade leading to the devastating neurodegenerative disease.

  • MGH and MIT form strategic partnership to address major challenges in clinical medicine - 10/15/2014, Research

    A novel partnership between Massachusetts General Hospital and Massachusetts Institute of Technology is addressing three major challenges in clinical medicine – improving the diagnosis of disease, developing new approaches to prevent and treat infectious and autoimmune diseases, and developing more accurate methods of diagnosing and treating major neurodegenerative and psychiatric diseases.

  • Study identifies potential treatment target for cocaine addiction - 10/29/2014, Research

    Investigators from MGH and the Perelman School of Medicine at the University of Pennsylvania have identified a potential target for therapies to treat cocaine addiction. Their study finds evidence that a small change in an important protein alters whether cocaine-experienced animals will resume drug seeking after a period of drug abstinence.

  • Mass General receives top honor for stroke patients’ quality of care - 3/20/2013, Mass General

    Massachusetts General Hospital (MGH) has received a top honor from the Massachusetts Department of Public Health (DPH) for its commitment to improving its quality of care to stroke patients. The “2013 Stroke Collaborative Reaching for Excellence (SCORE) Defect-Free Care Award” recognizes the MGH for providing defect-free care to more than 80 percent of patients admitted with stroke over the course of a year

  • Alzheimer's risk gene presents potential treatment target - 4/25/2013, Research

    MGH investigators have determined that one of the recently identified genes contributing to the risk of late-onset Alzheimer's disease regulates the clearance of the toxic amyloid beta (A-beta) protein that accumulates in the brains of patients with the disease.

  • Study finds evidence of nerve damage in around half of fibromyalgia patients - 7/30/2013, Research

    About half of a small group of patients with fibromyalgia – a common syndrome that causes chronic pain and other symptoms – was found to have damage to nerve fibers in their skin and other evidence of a disease called small-fiber polyneuropathy, a disorder that sometimes can be treated.

  • Use of tPA for ischemic stroke nearly doubled from 2003 to 2011 - 8/21/2013, Research

    Use of the "clot-busting" drug tissue plasminogen activator (tPA) to treat patients with strokes caused by a blockage of blood flow nearly doubled between 2003 and 2011, but not all eligible patients are receiving the potentially life-saving therapy.

  • Assay shown to be effective in measuring levels of mutant huntingtin protein - 8/29/2013, Research

    An assay designed to measure normal and abnormal forms of the huntingtin protein – the mutated form of which causes Huntington's disease – was successful in detecting levels of the mutant protein in a large multicenter study of individuals at risk for the devastating neurological disorder.

  • Study confirms that rare mutations increase risk of late-onset Alzheimer's disease - 9/24/2013, Research

    MGH researchers have identified and validated two rare gene mutations that appear to cause the common form of Alzheimer's disease (AD) that strikes after the age of 60. The two mutations occur in a gene called ADAM10, which now becomes the second pathologically-confirmed gene for late-onset AD and the fifth AD gene overall.

  • Study reveals how variant forms of APOE protein impact risk of Alzheimer's disease - 11/20/2013, Research

    A study led by MGH investigators shows that even low levels of the Alzheimer's-associated APOE4 protein can increase toxic amyloid beta brain plaques and the characteristic neuronal damage in mouse models of the disease. Introducing APOE2, a rare, potentially protective variant, reduced amyloid deposits and associated damage.

  • Study supports using virtual environment to teach mind/body techniques - 3/30/2012, Research

    A small study from MGH researchers found that online virtual communities may be an effective way to train patients in meditation and other mind/body techniques. The ability to learn and practice approaches that elicit the relaxation response in a virtual environment could help surmount several barriers that can restrict participation.

  • $5.4 Million Awarded for Research to Guide Alzheimer's Drug Development - 10/18/2012, Research

    Understanding who is most susceptible to Alzheimer's disease and developing early detection models, effective therapies and possibly a cure, is the goal of the largest single private scientific grant ever invested in Alzheimer's Whole Genome Sequencing focused on families afflicted with the disease.

  • Massachusetts General Hospital Launches Angelman Syndrome Clinic - 10/23/2012, Mass General

    The Angelman Syndrome Clinic, one of only two in the country, will work to reduce the frequency and severity of Angelman syndrome symptoms, particularly seizures, and to develop dietary regimens for individuals that further assist in the reduction of symptoms.

  • Genetic manipulation of urate alters neurodegeneration in mouse model of Parkinson's disease - 12/17/2012, Research

    A study by MGH researchers adds further support to the possibility that increasing levels of urate may protect against Parkinson's disease. The investigators report that mice with a genetic mutation increasing urate levels were protected against Parkinson's-like neurodegeneration, while the damage was worse in animals with abnormally low urate.

  • Statin risks may outweigh benefits for patients with a history of brain hemorrhage - 1/10/2011, Research

    A computer decision model suggests that for patients with a history of bleeding within the brain, the risk of recurrence associated with statin treatment may outweigh the benefit of the drug in preventing cardiovascular disease, according to a report posted online today that will appear in the May print issue of Archives of Neurology.

  • Tumor microvesicles reveal detailed genetic information - 2/10/2011, Research

    The MGH research team that previously discovered tumor-associated RNA in tiny membrane-enclosed sacs released into the bloodstream by cancer cells has now found that these microvesicles also contain segments of tumor DNA, including so-called "jumping genes" that copy and insert themselves into other areas of the genome.

  • Advanced technology reveals activity of single neurons during seizures - 3/27/2011, Research

    The first study to examine the activity of hundreds of individual human brain cells during seizures has found that seizures begin with extremely diverse neuronal activity, contrary to the classic view that they are characterized by massively synchronized activity.

  • BrainGate neural interface system reaches 1,000-day performance milestone - 3/24/2011, Research

    An investigational implanted system being developed to translate brain signals toward control of assistive devices has allowed a woman with paralysis to accurately control a computer cursor at 2.7 years after implantation, providing a key demonstration that neural activity can be read out and converted into action for an unprecedented length of time.

  • Mild obesity appears to improve survival in ALS patients - 5/11/2011, Research

    Patients with amyotrophic lateral sclerosis (ALS) may be an exception to the rule that being overweight is a health hazard. In a retrospective study of over 400 ALS patients, MGH researchers found that those who were mildly obese survived longer than patients who were normal weight, underweight or even overweight.

  • Biomarker for Huntington's disease identified - 10/3/2011, Research

    In a new research paper BWH and MGH researchers identify a transcriptional biomarker that may assist in the monitoring of Huntington's disease activity and in the evaluation of new medications.

  • Novel ALS drug slows symptom progression, reduces mortality in phase 2 trial - 11/20/2011, Research

    Treatment with dexpramipexole – a novel drug believed to prevent dysfunction of mitochondria, the subcellular structures that provide most of a cell's energy – appears to slow symptom progression in the neurodegenerative disease amyotrophic lateral sclerosis (ALS), also called Lou Gehrig's disease.

  • Rebuilding the Brain’s Circuitry - 11/24/2011, Research

    Neuron transplants have repaired brain circuitry and substantially normalized function in mice with a brain disorder, an advance indicating that key areas of the mammalian brain are more reparable than was widely believed.

  • Alzheimer's-associated protein may be part of the innate immune system - 3/2/2010, Research

    Amyloid-beta protein – the primary constituent of the plaques found in the brains of Alzheimer's disease patients – may be part of the body's first-line system to defend against infection. In their report in the March 3 issue of PLoS One, a team led by MGH researchers describe their evidence that amyloid-beta protein is an antimicrobial peptide.

  • Brain rhythm predicts ability to sleep through a noisy night - 8/9/2010, Research

    People who have trouble sleeping in noisy environments often resort to strategies like earplugs or noise-canceling headphones that muffle the sound, but a new study from MGH investigators may lead to ways to block disturbing sounds within the brain.

  • International collaboration identifies new gene associated with ALS - 2/26/2009, Research

    A collaborative research effort spanning nearly a decade between researchers at Massachusetts General Hospital and King’s College London has identified a novel gene for inherited amyotrophic lateral sclerosis (ALS, also known as Lou Gehrig’s disease).

  • Videoconferencing can increase patient access to stroke specialists - 5/8/2009, Research

    High-quality videoconferencing can increase patient access to stroke specialists; and a transient ischemic attack, once known as a “mini” or “warning” stroke, should be treated with the same urgency as a full-blown stroke, according to two separate statements published today in Stroke.

  • Mass. General’s Rudy Tanzi a “Rock Star of Science” - 5/26/2009, Research

    Alzheimer’s disease researcher Rudolph Tanzi, PhD, of Massachusetts General Hospital adds another distinction to his scientific career when he joins Aerosmith’s Joe Perry and other rock celebrities in a designer menswear photo shoot as a “Rock Star of Science” in the June issue of GQ Magazine.

  • Antiangiogenesis treatment improves hearing in some NF2 patients - 7/8/2009, Research

    Treatment with the angiogenesis inhibitor bevacizumab improved hearing and alleviated other symptoms in patients with neurofibromatosis type 2 (NF2). The study by researchers from Massachusetts General Hospital (MGH) represents the first report of a successful NF2 treatment not involving surgery or radiation.

  • Study supports possible role of urate in slowing Parkinson’s disease progression - 10/12/2009, Research

    By examining data from a 20-year-old clinical trial, a research team based at the MassGeneral Institute for Neurodegenerative Diseases and Harvard School of Public Health, has found evidence supporting the findings of their 2008 study – that elevated levels of the antioxidant urate may slow the progression of Parkinson’s disease.


Currently Browsing:2014

  • NeuroImage: Clinical

    Monday, December 22, 2014

    Evidence from human post mortem, in vivo and animal model studies implicates the neuroimmune system and activated microglia in the pathology of amyotrophic lateral sclerosis.

Currently Browsing:2013

  • The Lancet: Neurology

    Monday, September 23, 2013

    In a phase III trial, dexpramipexole was generally well tolerated but did not differ from placebo on any pre-specified efficacy endpoint measurement. The trial can inform the design of future clinical research strategies in amyotrophic lateral sclerosis.

Currently Browsing:2012

  • Stem Cells

    Tuesday, March 13, 2012

    The results of an ongoing Phase I trial of intraspinal injections of fetal-derived neural stems cells in patients with ALS.
  • Amyotrophic Lateral Sclerosis

    Wednesday, May 16, 2012

    Published Phase II results demonstrated that single oral doses of 250 mg and 500 mg of CK-2017357 appeared safe and well-tolerated in patients with ALS.
  • MIND Research Review

    Saturday, December 15, 2012

    A review of research at the Massgeneral Institute for Neurodegenerative Disease.

Currently Browsing:2010

  • Lancet Neurology

    Saturday, May 01, 2010

    Double-blind, placebo-controlled trial with a time-to-event design assessing the safety and efficacy of lithium in combination with riluzole in patients with ALS.
  • Therapy Times

    Sunday, May 23, 2010

    Paige Nalipinski, senior speech language pathologist and project coordinator at MGH, writes about ALS care guidelines and her experience working with patients at the MGH ALS Multidisciplinary Clinic.

Currently Browsing:2009

  • Dystonia Newsletter 2009

    Sunday, November 01, 2009

    The “Dystonia Update” is an annual newsletter from the research laboratories of Xandra O. Breakefield, PhD and Nutan Sharma, MD, PhD about dystonia research at Massachusetts General Hospital. In the newsletter you will learn about ongoing research projects and the people behind dystonia research, and find answers to commonly asked questions.

Currently Browsing:2008

  • Muscle & Nerve

    Tuesday, July 01, 2008

    Safety, tolerability, and pharmacokinetics of arimoclomol in ALS were assessed.

Currently Browsing:2007

  • Dystonia Update Annual Newsletter

    Saturday, December 01, 2007

    The “Dystonia Update” is an annual newsletter from the research laboratories of Xandra O. Breakefield, PhD and Nutan Sharma, MD, PhD about dystonia research at Massachusetts General Hospital. In the newsletter you will learn about ongoing research projects and the people behind dystonia research, and find answers to commonly asked questions.

Currently Browsing:2006

  • Dystonia Newsletter 2006

    Friday, December 01, 2006

    The “Dystonia Update” is an annual newsletter from the research laboratories of Xandra O. Breakefield, PhD and Nutan Sharma, MD, PhD about dystonia research at Massachusetts General Hospital. In the newsletter you will learn about ongoing research projects and the people behind dystonia research, and find answers to commonly asked questions.
  • Annals of Neurology

    Saturday, July 01, 2006

    A double-blind, placebo-controlled, clinical trial to determine if celecoxib is safe and effective in ALS.
  • Dystonia Update 2006

    Friday, December 15, 2006

    The “Dystonia Update” is an annual newsletter from the research laboratories of Xandra O. Breakefield, PhD and Nutan Sharma, MD, PhD about dystonia research at Massachusetts General Hospital. In the newsletter you will learn about ongoing research projects and the people behind dystonia research, and find answers to commonly asked questions.

Currently Browsing:2005

  • Neurology

    Tuesday, December 13, 2005

    An open-label dose-escalation trial was performed to assess the safety and tolerability of high doses of coenzyme Q10 (CoQ10) in ALS.

Currently Browsing:2004

  • Neurology

    Tuesday, November 09, 2004

    A randomized double-blind, placebo controlled trial on 104 patients with ALS from 14 sites to evaluate the efficacy of creatine supplementation in ALS.

Currently Browsing:2003

  • Neurology

    Tuesday, August 26, 2003

    A double-blind, placebo-controlled, multicenter randomized clinical trial to determine if long-term topiramate therapy is safe and slows disease progression in patients with ALS.


Currently Browsing:2017

  • Neurorehabilitation 2017

    Thursday, June 15, 2017

    The Comprehensive Neurorehabilitation Update for Clinicians Who Provide Care for Patients with CNS Trauma and Neurological Diseases

Currently Browsing:2016

  • Neurological Emergencies

    Thursday, September 22, 2016

    When patients complain of headache, dizziness, weakness or back pain, how do you determine which is an emergency? This special program provides state-of-the-art approaches and tools to quickly and effectively determine which cases are emergencies, and how to treat them.
  • MGH Pediatric Epilepsy Program's Annual Taking Epilepsy to College

    Tuesday, June 28, 2016

    Massachusetts General Hospital, 32 Fruit Street, Boston, Mass. Yawkey Outpatient Center - 2nd Floor: Room 2-210 for Students and Room 2-220 for Parents
  • Dementia: A Comprehensive Update

    Wednesday, June 08, 2016

    The spectrum of neurodegenerative diseases spans from very mild cognitive impairment to frank dementia. Alzheimer’s disease (AD), the most common cause of dementia, is a devastating condition that affects patients and their whole family of caregivers at tremendous emotional as well as financial cost.
  • Jake's Ride

    Sunday, May 01, 2016

    Please join us on Sunday, May 1, 2016, in Short Hills, NJ for Jake’s Ride! A generous portion of the funds raised will go to support Movement Disorder Fellowship training at here at Mass General!

Currently Browsing:2015

Currently Browsing:2014

Currently Browsing:2013

  • MGH Russell Museum Lunchtime Lecture Series

    Tuesday, December 10, 2013

    Paul S. Russell, MD Museum of Medical History and Innovation invites you to attend its latest lecture in its lunchtime series
  • "The Art of Illness"

    Tuesday, November 12, 2013

    The Massachusetts General Hospital Paul S. Russell, MD Museum of Medical History and Innovation Lecture Series invites you to attend the next in its series of free monthly evening lectures.
  • Neurology Grand Rounds

    Thursday, July 18, 2013

    Neurology Grand Rounds are held in the Ether Dome on Thursdays 9:00 am to 10:00 am.
  • 3rd Annual Christopher Leavitts Memorial Motorcycle Ride

    Saturday, May 18, 2013

    Join us for the 3rd Annual Christopher Leavitts Memorial Motorcycle Ride on Saturday, May 18th in Everett, to benefit head trauma research at Mass General.
  • Beautiful Brain with Marie Pasinski, MD

    Wednesday, March 06, 2013

    Harvard neurologist, Dr. Marie Pasinski, MD will talk about keeping your brain healthy.

Currently Browsing:2012


  • Video about Parkinson's and LBD research

    Parkinson's Symposium at MIND- 2008

    Momentum in our Pursuit of Cures - Research advances in Parkinson's, Lewy Body dementia, and Parkinson's-Plus disorders. Anne B. Young, MD, PhD, Director, MassGeneral Institute for Neurodegenerative Disease (MIND), formerly Chief of Neurology Service.

  • Michael Jaff, DO, explains how knowing your personal and family history may help prevent a stroke

    Michael Jaff, DO, explains how knowing your personal and family history may help prevent a stroke

    Michael Jaff, DO, Medical Director of the Massachusetts General Hospital Fireman Vascular Center explains how carotid artery disease can cause a stroke, unless it is found early and treated, and how you can identify your risk for this condition.

  • Guy Rordorf, MD, recommends an imaging test for anyone with a family history of FMD

    Guy Rordorf, MD, recommends an imaging test for anyone with a family history of FMD

    Guy Rordorf, MD, vascular neurologist at the Massachusetts General Hospital Fireman Vascular Center, says an imaging test can detect fibromuscular dysplasia (FMD), and recommends it for those with a family history of the condition. Learn more about FMD and how it weakens artery walls and can lead to severe hypertension or stroke.

  • Learn more about MIND

    Learn more about MIND

    The Mass General Institute for Neurodegenerative Disease (MIND) is poised to change the future for people with Alzheimer’s, ALS (Lou Gehrig’s), Huntington’s, and Parkinson’s diseases. Discover MIND and see what we are doing to accelerate research discoveries that will lead to treatment and cures for memory, movement, and neuromuscular disorders.

  • Celebrating 200 Years: 1811 - 2011

    Celebrating 200 Years: 1811 - 2011

    Since 1811, people have counted on Mass General for answers, innovations and medical leadership. As our third century dawns, we remain ready to serve.

  • Ceftriaxone in ALS Webinar

    The Clinical Trial of Ceftriaxone in ALS

    A webinar recording explaining the design and scientific rationale behind the Clinical Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease.

  • Ceftriaxone in ALS Video

    Ceftriaxone Trial Video

    A video explaining the design and scientific rationale behind the Clinical Trial of Ceftriaxone in Amyotrophic Lateral Sclerosis (ALS), commonly known as Lou Gehrig's disease.

  • Neurology bicentennial logo

    Neurology Bicentennial Celebration, 2011 Part I

    Neurology Bicentennial Celebration, October 13, 2011. Past History of MGH Neurology; Overview of MGH Neurology; Telestroke and Acute Stroke Service; Neurodegenerative Disorders; Pediatric Neurology.

  • Neurology bicentennial logo

    Neurology Bicentennial Celebration, 2011 Part II

    Neurology Bicentennial Celebration, October 13, 2011. Clinical and research presentations on ALS, Stroke, Alzheimer’s Disease, and Parkinson’s Disease

  • Neurology bicentennial logo

    Neurology Bicentennial Celebration 2011 II HD

    Neurology Bicentennial Celebration, October 13, 2011. Clinical and research presentations on Huntington’s Disease, Epilepsy, and Neuro-Oncology.

  • respiratory assistance video

    Respiratory Assistance Video

    A video for ALS patients discussing and demonstrating uses of bipap and cough assist machines.

  • Young stroke victim recovers from basilar artery occlusion

    A young stroke victim experiences a dramatic recovery

    A young stroke victim experiences a dramatic recovery from a life threatening basilar artery occlusion with the help of the Acute Stroke Team and Dr. Aneesh Singhal. Also featuring Dr. Lee Schwamm.

  • A young epileptic patient regains normalcy

    Treatment for epileptic seizures in young patient

    Treatment for epileptic seizures with Dr. Thiele and brain surgery performed by Dr. Duhaime help this young epileptic patient regain normalcy after experiencing up to 12 seizures daily.

  • young man recovers from seizures and coma

    A young man recovers from seizures and coma

    The Neuro Critical Care Team’s excellence in service and innovation bring a young man back to life after epileptic seizures leave him comatose for five months. Features Dr. Rosand and Dr. Cole.

  • Frontal Temporal Dementia

    Patient diagnosed with Frontal Temporal Dementia

    A gripping story of a young man diagnosed with Frontal Temporal Dementia by Dr. Brad Dickerson.

  • Dr. Marie Pasinski speaking with a monk

    Community Health

    MGH doctors Nicte Mejia-Gonzalez and Marie Pasinski talk about providing neurological care to patients at MGH Community Health Care centers.

  • Partners Neurology Residents at Mass General

    Partners Neurology Residency

    Neurology residents, program graduates, faculty members, and the education director talk about training at Mass General Hospital and Brigham and Women’s Hospital.

  • Mr. Elton

    Epilepsy: The Road to a Cure

    A young man's quest to find a cure for his epileptic seizures takes him on a journey from Albania to Boston.

  • Welcome for Patients

    ALS Patient Video

    Nicole from Boston, shares her story about her battle with ALS and her strong desire to help others with the disease in the future. Mass General's ALS Multidisciplinary Clinic provides the latest treatments and research opportunities for people with Amyotrophic Lateral Sclerosis.

  • Dr. Cudkowicz

    Patient Welcome from Dr. Cudkowicz

    Dr. Merit Cudkowicz, Neurology's Chief of Service, shares what makes the Mass General ALS Multidisciplinary Clinic so special.

  • Acute Stroke Care: When Time is Critical

    Acute Stroke Care: When Time is Critical

    13 days after giving birth to her son, a young woman suffers a stroke and makes a miraculous recovery. Features Dr. Leslie-Mazwi, Dr. Mehta and Dr. Musolino.

  • Acute Stroke Care: When Time is Critical

    Acute Stroke Care: When Time is Critical

    13 days after giving birth to her son, a young woman suffers a stroke and makes a miraculous recovery. Features Dr. Leslie-Mazwi, Dr. Mehta and Dr. Musolino.Acute Stroke Care: When Time is Critical

  • Dr. Merit Cudkowicz, recipient of MDA LOU GEHRIG HUMANITARIAN AWARD

    Congratulations to Dr. Merit Cudkowicz for receiving the MDA LOU GEHRIG HUMANITARIAN AWARD

    Congratulations to Dr. Merit Cudkowicz, MGH Neurology Department Chairperson and Director, MGH ALS Clinic, for receiving the MDA LOU GEHRIG HUMANITARIAN AWARD. This award is given to a researcher, physician, or clinician who supports MDA/ALS research initiatives and clinical services and continues to fight the battle against ALS. View her acceptance speech where she discusses reasons for hope in the future of ALS treatments.

  • ALS Symposium

    MGH ALS Symposium Video

    Hear from the MGH Neurology Department Chairperson and founder and member of the MGH ALS Multidisciplinary Clinic, Dr. Merit Cudkowicz; Director of the MGH Multidisciplinary Care Clinic, Dr. James Berry; as well as the many researchers and clinic staff dedicated to finding treatments and cures for ALS.

  • ALS Walk of Hope

    ALS Walk of Hope

    Learn how the Walk of Hope, sponsored by the ALS Raising Hope Foundation ( raises funds for neurodegenerative disease research at MIND-and how researchers are using it to find cures.

  • Dylan and Family

    Dr. Brian Edlow, with former patient Dylan Rizzo and parents in the NeuroICU last week. Dylan is a former patient of Dr. Edlow's, who returned to talk to faculty at Thursday's noon conference about his unexpected recovery from a severe traumatic brain injury.

  • Jessica’s Story: A Stroke Survivor

    Jessica's Story: A Stroke Survivor

    Jessica Diaz had a stroke caused by a small hole in the heart, which had allowed a blood clot to travel to her brain. As a young and active mother of two, Jessica worked with a team of Mass General doctors to not only repair her heart, but determine a treatment plan to minimize future health risks.

  • Diagnosing TSC

    Diagnosing TSC

    Neurologist Elizabeth Thiele explains that diagnosis of TSC is based on the clinical features common in the disorder.

Back to Top